This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Brainsway is happy to announce that TRICARE insurance now covers Brainsway’s Deep TMS Therapy. The new coverage gives 9.6 million people access to this non-invasive treatment of major depressive disorder.
Tricare is health care program that provides benefits for members of the US Armed Forces, as well as their families and dependents. Their contractors are Humana in the South, Health Net in the North, and United HealthCare in the West.
We are happy that members of Armed Forces and their families now have insured access to Deep TMS Treatment. Brainsway will continue working to help change the way depression is treated.